Topic Hubs
AI drug discovery: News, analysis and interviews
Antibody-drug conjugates: The next wave of targeted cancer drugs
Biopharma M&A and dealmaking: Who’s buying and why
Biopharma people moves: CEO changes, executive hires, board positions
Biotech IPOs: Tracking the market for new public offerings
Biotech venture funding: Who’s raising and where the money is going
Cell and gene therapy manufacturing: Scaling the next frontier
China biotech: Licensing deals and the Biosecure Act
CRISPR and gene editing: The push for in vivo therapies
Drug pricing and the IRA: Tracking the government's negotiation power
FDA policy and drug approvals: What’s changing for biopharma
GLP-1 drugs: The obesity pipeline race and what's next
Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Signal
More
Work at Endpoints
Biopharma Jobs
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
{@!--LOGTO_LOGIN_BUTTON--!@}
Health tech funding rises to $7.4B in the first half of 2026
4 minutes ago
Health Tech
Biopharma's 'extraordinary year' for M&A sets tone as earnings cycle begins
1 hour ago
Deals
Pharma
Tris Pharma's CRL for narcolepsy drug; Agenus abandons Phase 3 CRC trial
1 hour ago
News Briefing
Deals, deals, deals; Biohaven takes on Eli Lilly; and more
2 days ago
Weekly
Apnimed files for IPO as FDA reviews its sleep apnea drug
2 days ago
Deals
IPOs
FDA returns to releasing pharma rejection letters with 14 new CRLs
2 days ago
FDA+
FDA rejects Hengrui-Elevar liver cancer drug combo for third time
2 days ago
China
FDA+
CDER adds 100+ new employees in a quarter for first time since late 2024
2 days ago
People
FDA+
'We're paranoid.' As China biotech competition heats up, American drugmakers get more secretive
3 days ago
R&D
China
German lawmakers pass cost-saving bill that drugmakers say will drive them out
3 days ago
Pharma
Law
Hansoh meets Phase 3 SCLC goal; FDA approves Sanofi on-body injector
3 days ago
News Briefing
The data that led an AI biotech to pick up Novo's Parkinson's stem cell therapy
3 days ago
R&D
Cell/Gene Tx
Pfizer appoints obesity discovery head; AI startup Xaira makes leadership adjustments
3 days ago
Peer Review
ARPA-H bookmarks $160M for custom gene editing treatments. Is it enough?
3 days ago
R&D
Cell/Gene Tx
HHS advances plan to pay out Covid-19 vaccine injury claims
3 days ago
Pharma
FDA+
Roche ends work on tominersen after decade of trials, as well as early-stage Huntington’s asset
3 days ago
R&D
UK price watchdog recommends against Amgen's Lumakras in lung cancer
3 days ago
Pharma
FDA+
FDA criticizes Lundbeck for webpages promoting migraine treatment Vyepti
3 days ago
FDA+
FDA quietly stops releasing CRLs
4 days ago
FDA+
Manufacturing
The biggest health tech stories of 2026 — so far
4 days ago
Health Tech
Ipsen succeeds in migraine trials; Tarsus buys iRenix for $75M upfront
4 days ago
News Briefing
Lilly was already pharma's biggest company. Now it's doing deals to match
4 days ago
Deals
Pharma
Catalent to divest UK site; Rottendorf, Evonik announce manufacturing builds
4 days ago
Manufacturing
GSK walks away from Alector pact as immuno-neurology bet fizzles
4 days ago
Deals
Pharma
1
2
3
4
Next page
Last page